University of Southern California Keck School of Medicine: New Compound Targets Circadian Clock Machinery in Cells to Fight Glioblastoma
May 13, 2025
May 13, 2025
LOS ANGELES, California, May 13 -- The University of Southern California Keck School of Medicine issued the following news:
* * *
New compound targets circadian clock machinery in cells to fight glioblastoma
In research led by the Keck School of Medicine of USC, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a phase 1 clinical trial.
A series of preclinical studies show that a new compound . . .
* * *
New compound targets circadian clock machinery in cells to fight glioblastoma
In research led by the Keck School of Medicine of USC, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a phase 1 clinical trial.
A series of preclinical studies show that a new compound . . .